Laddar...
Seamless Phase I/II Adaptive Design For Oncology Trials of Molecularly Targeted Agents
In dose-finding trials of chemotherapeutic agents, the goal of identifying the maximum tolerated dose is usually determined by considering information on toxicity only, with the assumption that the highest safe dose also provides the most promising outlook for efficacy. Trials of molecularly targete...
Sparad:
| I publikationen: | J Biopharm Stat |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363077/ https://ncbi.nlm.nih.gov/pubmed/24904956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2014.920873 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|